Literature DB >> 9422341

Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease.

M P Mattson1, Q Guo, K Furukawa, W A Pedersen.   

Abstract

Many cases of autosomal dominant inherited forms of early-onset Alzheimer's disease are caused by mutations in the genes encoding presenilin-1 (PS-1; chromosome 14) and presenilin-2 (PS-2; chromosome 1). PSs are expressed in neurons throughout the brain wherein they appear to be localized primarily to the endoplasmic reticulum (ER) of cell bodies and dendrites. PS-1 and PS-2 show high homology and are predicted to have eight transmembrane domains with the C terminus, N terminus, and a loop domain all on the cytosolic side of the membrane; an enzymatic cleavage of PSs occurs at a site near the loop domain. The normal function of PSs is unknown, but data suggest roles in membrane trafficking, amyloid precursor protein processing, and regulation of ER calcium homeostasis. Homology of PSs to the C. elegans gene sel-12, which is involved in Notch signaling, and phenotypic similarities of PS-1 and Notch knockout mice suggest a developmental role for PSs in the nervous system. When expressed in cultured cells and transgenic mice, mutant PSs promote increased production of a long form of amyloid beta-peptide (A beta1-42) that may possess enhanced amyloidogenic and neurotoxic properties. PS mutations sensitize cultured neural cells to apoptosis induced by trophic factor withdrawal, metabolic insults, and amyloid beta-peptide. The mechanism responsible for the proapoptotic action of mutant PSs may involve perturbed calcium release from ER stores and increased levels of oxidative stress. Recent studies of apoptosis in many different cell types suggest that ER calcium signaling can modulate apoptosis. The evolving picture of PS roles in neuronal plasticity and Alzheimer's disease is bringing to the forefront the ER, an organelle increasingly recognized as a key regulator of neuronal plasticity and survival.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9422341     DOI: 10.1046/j.1471-4159.1998.70010001.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  35 in total

Review 1.  Presenilins: structural aspects and posttranslational events.

Authors:  F Checler
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

Review 2.  The role of presenilins in Alzheimer's disease.

Authors:  G Thinakaran
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

3.  C-terminal maturation fragments of presenilin 1 and 2 control secretion of APP alpha and A beta by human cells and are degraded by proteasome.

Authors:  C A da Costa; K Ancolio; F Checler
Journal:  Mol Med       Date:  1999-03       Impact factor: 6.354

Review 4.  The role of cell cycle-mediated events in Alzheimer's disease.

Authors:  A K Raina; M J Monteiro; A McShea; M A Smith
Journal:  Int J Exp Pathol       Date:  1999-04       Impact factor: 1.925

Review 5.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

6.  Calsenilin reverses presenilin-mediated enhancement of calcium signaling.

Authors:  M A Leissring; T R Yamasaki; W Wasco; J D Buxbaum; I Parker; F M LaFerla
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

7.  Replicating neuroblastoma cells in different cell cycle phases display different vulnerability to amyloid toxicity.

Authors:  Cristina Cecchi; Anna Pensalfini; Massimo Stefani; Serena Baglioni; Claudia Fiorillo; Silvia Cappadona; Roberto Caporale; Daniele Nosi; Marco Ruggiero; Gianfranco Liguri
Journal:  J Mol Med (Berl)       Date:  2007-09-22       Impact factor: 4.599

8.  Amyloid-beta induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity.

Authors:  R Varma; Y Chai; J Troncoso; J Gu; H Xing; S S Stojilkovic; M P Mattson; N J Haughey
Journal:  Neuromolecular Med       Date:  2009-06-27       Impact factor: 3.843

Review 9.  The role of apoptosis in neurodegenerative diseases.

Authors:  P Desjardins; S Ledoux
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

Review 10.  ER stress and the unfolded protein response in neurodegeneration.

Authors:  Claudio Hetz; Smita Saxena
Journal:  Nat Rev Neurol       Date:  2017-07-21       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.